MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0094740
Epigeneres Biotech Private Limited - life sciences in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.42 Cr
▲ 185% YoY
Net loss · FY 2025
₹17.26 Cr
Net margin -232.7%
EBITDA · FY 2025
-₹6.71 Cr
EBITDA margin -90.4%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹2.56 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
76
Provident fund records
Directors on board
7
As per MCA filings
About Epigeneres Biotech Private Limited
Data last updated:
Epigeneres Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 25 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U29253MH2012PTC230235. Its GSTIN is 27AABCU4383J1Z0 (Maharashtra).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2.56 Lakh. It was formerly known as Trivinay Bio-Tech Private Limited and Usvi Bio-Tech Private Limited. It is led by directors including Anish Tripathi (Managing Director) and Bhavna Roy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Todi Building Mathuradas Mill Compound Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹17.26 Cr (net margin -232.7%) and EBITDA of -₹6.71 Cr (EBITDA margin -90.4%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years and 59% over five years.
The company has about 76 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Epigeneres. Court records list 3 cases involving the company, including 3 filed by the company. The company has 16 deals on record (12 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹63.42 Cr; the latest was in June 2024. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Allied Biotechnology India Private Limited with revenue of ₹7.61 Cr.
Epigeneres Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0094740). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website epigeneres.com.
Company Details of Epigeneres Biotech Private Limited
CIN U29253MH2012PTC230235
Registration Number 230235
Incorporation Date 25 April 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0094740
Name History of Epigeneres Biotech Private Limited
Epigeneres Biotech has undergone 2 name changes throughout its history. The company was previously known as Trivinay Bio-Tech Private Limited, and Usvi Bio-Tech Private Limited. The current legal name is Epigeneres Biotech Private Limited.
| Company Name | Status |
|---|---|
| Epigeneres Biotech Private Limited | Current |
| Trivinay Bio-Tech Private Limited | Previous |
| Usvi Bio-Tech Private Limited | Previous |
Recognitions & Rankings of Epigeneres Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1st Floor Todi Building Mathuradas Mill Compound Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Epigeneres Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Epigeneres Biotech Private Limited
Epigeneres Biotech operates one associated brand: Epigeneres. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Genomics-based cancer diagnostic tests are offered by Epigeneres. | epigeneres.com |
Business Activity of Epigeneres Biotech Private Limited
The main business activity of Epigeneres Biotech is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Epigeneres Biotech Private Limited FY 2025 filings available
Epigeneres Biotech Private Limited reported revenue of ₹7.42 Cr (up 185% YoY) for FY 2025.
Revenue · FY 2025
₹7.42 Cr ▲ 185%
Net loss · FY 2025
₹17.26 Cr margin -232.7%
EBITDA · FY 2025
-₹6.71 Cr margin -90.4%
Compounded Annual Growth Rate (CAGR) of Epigeneres Biotech Private Limited
Revenue CAGR growth
1 year
▲ 185%
3 years · compounded
▲ 57%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▼ 57%
5 years · compounded
▼ 35%
Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 185% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Epigeneres Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹6.71 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹17.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Epigeneres Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -90.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -232.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Epigeneres Biotech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Epigeneres Biotech Private Limited
Epigeneres Biotech has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavna Roy Also directs: Tzar Labs India Equipment LLP, Sai Leela Technologies Private Limited, Himanshu Roy Foundation and 1 more | Director | 10 Jan 2022 | 4 Years 9 Months | Current |
| Krishnan Venkata Challam | Director | 29 Feb 2016 | 10 Years 7 Months | Current |
| Anish Tripathi | Managing Director | 05 May 2019 | 7 Years 5 Months | Current |
| Sanjay Pravinchandra Also directs: Pheo Para Foundation | Director | 30 Sep 2023 | 3 Years 0 Months | Current |
| Moez Rajabali Rahemtulla Daya | Nominee Director | 10 Jan 2022 | 4 Years 9 Months | Current |
| Ashish Vinaykumar Tripathi Also directs: Kaaljayi Media LLP | Director | 29 Feb 2016 | 10 Years 7 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer Comparison of Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allied Biotechnology India Private Limited | ₹7.61 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Hyderabad, Telangana, India |
| Rutu Biosys Private Limited | ₹7.61 Cr (FY 2025) | •••• | •••• | 71.0% | •••• | Pune, Maharashtra, India |
| Dhiti Diagnostics Private Limited | ₹7.58 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Amspro Biotech Private Limited | ₹7.57 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Hyderabad, Telangana, India |
| Cielo Biotech Private Limited | ₹7.42 Cr (FY 2022) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Epigeneres Biotech Private Limited this company | ₹7.42 Cr (FY 2025) | •••• | •••• | 185.0% | •••• | Mumbai, Maharashtra, India |
| Biozone Life Sciences Private Limited | ₹7.36 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Shrirampur, Maharashtra, India |
| Bio-Techne India Private Limited | ₹7.35 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Nivshakti Bioenergy Private Limited | ₹7.34 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
| Dhiti Omics Technologies Private Limited | ₹7.24 Cr (FY 2025) | •••• | •••• | 342.0% | •••• | Bangalore, Karnataka, India |
| Bencos Research Solutions Private Limited | ₹7.24 Cr (FY 2025) | •••• | •••• | 67.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Epigeneres Biotech by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited is audited by JHS & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JHS & Associates LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Epigeneres Biotech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited has 16 deals on record (12 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹63.42 Cr; the latest was in June 2024.
Total deals
16
Secondary share transfers
12
Funding rounds
3
Rights issue
1
Disclosed funding
₹63.42 Cr
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Rights issue | ₹16.63 Cr | Investors: Aurora Borealis Consultancy LLP , 3 individuals |
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: Axia Enterprises Private Limited Seller: Mahati Electrics Engineering Services LLP |
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: Mahati Electrics Engineering Services LLP Seller: Mahati Hydro Power Projects Private Limited |
| Dec 2021 | Funding round | ₹45.42 Cr | Investors: LVX (LetsVenture), Kotak Private Equity, 2 individuals |
| Jun 2018 | Funding round | ₹12 Cr | Investors: Torrents Pharmaceuticals Private Limited, 3 individuals |
Premium access
Full deal history
All 16 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited has 3 court cases on record: 3 filed by Epigeneres Biotech. All cases are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
3
Filed by the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMMP) | Filed by the company against Registrar of Trade Marks, Trademark Registry | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Registrar of Trade Marks, Trademark Registry | Disposed |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited has a workforce of 76 employees as of Apr 09, 2024.
Employee count
76
Active EPFO establishments
1
Employee growth
22.58%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited has 15 board changes on record since 2016: 7 appointments and 8 cessations. The latest: Sanjay Pravinchandra was appointed as Director on 30 Sep 2023.
AGM
Epigeneres Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Epigeneres Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Sanjay Pravinchandra was appointed as Director.
Ceased
Bhavna Roy ceased to be Additional Director.
Ceased
Shailesh Vishnubhai Haribhakti ceased to be Nominee Director.
Ceased
Anish Tripathi ceased to be Director.
Appointed
Bhavna Roy was appointed as Director.
Appointed
Moez Rajabali Rahemtulla Daya was appointed as Nominee Director.
Ceased
Amish Tripathi ceased to be Additional Director.
Appointed
Amish Tripathi was appointed as Director.
Appointed
Anish Tripathi was appointed as Managing Director.
Ceased
Vinaykumar Babulal Tripathi ceased to be Director.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Epigeneres Biotech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Epigeneres Biotech Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Epigeneres Biotech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Epigeneres Biotech Private Limited
Epigeneres Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCU4383J1Z0 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Epigeneres Biotech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Epigeneres Biotech Private Limited
Frequently Asked Questions about Epigeneres Biotech Private Limited
Epigeneres Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 25 April 2012 (14+ years old) and is registered under CIN U29253MH2012PTC230235.
Epigeneres Biotech reported revenue of ₹7.42 Cr for FY 2025 (up 185% YoY).
Epigeneres Biotech has 7 current directors:
- Anish Tripathi - Managing Director
- Bhavna Roy - Director
- Krishnan Venkata Challam - Director
- Sanjay Pravinchandra - Director
- Moez Rajabali Rahemtulla Daya - Nominee Director
- Ashish Vinaykumar Tripathi - Director
- Amish Tripathi - Director
Epigeneres Biotech reported a net loss of ₹17.26 Cr (net margin -232.7%) and EBITDA of -₹6.71 Cr (EBITDA margin -90.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Epigeneres Biotech is 57% over three years and 59% over five years. In the latest year (FY 2025) revenue rose 185%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Epigeneres Biotech is 27AABCU4383J1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Epigeneres Biotech is U29253MH2012PTC230235. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epigeneres Biotech has 3 court cases on record: 3 filed by the company.
Epigeneres Biotech was incorporated on 25 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Epigeneres Biotech has 16 deals on record (12 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹63.42 Cr; the latest was in June 2024.
The peers of Epigeneres Biotech by revenue are Allied Biotechnology India Private Limited, Rutu Biosys Private Limited, Dhiti Diagnostics Private Limited, Amspro Biotech Private Limited, Cielo Biotech Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).